Foundry Partners, LLC - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 254 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.

Quarter-by-quarter ownership
Foundry Partners, LLC ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$5,426,000
-15.6%
89,419
-2.5%
0.19%
-11.8%
Q1 2021$6,427,000
+13.3%
91,690
-3.3%
0.21%
-5.4%
Q4 2020$5,675,000
+0.3%
94,843
+0.8%
0.22%
-18.3%
Q3 2020$5,657,000
+12.9%
94,102
-1.5%
0.27%
+11.4%
Q2 2020$5,012,00095,5280.24%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Prosight Management, LP 1,210,377$37,134,36611.77%
Gagnon Advisors, LLC 180,331$5,532,5554.63%
GAGNON SECURITIES LLC 565,429$17,347,3614.35%
ARDSLEY ADVISORY PARTNERS LP 310,000$9,510,8002.12%
RICE HALL JAMES & ASSOCIATES, LLC 968,485$29,713,1201.89%
AlphaCentric Advisors LLC 103,000$3,160,0401.79%
1492 Capital Management LLC 79,687$2,444,7971.58%
ARDSLEY ADVISORY PARTNERS LP 149,000$4,571,3201.02%
OUTFITTER FINANCIAL LLC 32,305$991,1170.93%
Rock Springs Capital Management LP 1,055,500$32,382,7400.87%
View complete list of PACIRA PHARMACEUTICALS INC shareholders